Study looked at 39 patients with bone metastases previously treated with radiotherapy. All patients were radiotherapy-resistant.
A median reduction of 50% in pain was observed among the patients in the vitamin C group.
2.5g vitamin C infusion daily saw a median survival time of 10 months whereas the chemotherapy and control groups experienced a median survival of just 2 months.
2.5g vitamin C infusion daily reduced pain in patients in comparison to other patients who did not receive it.
2.5g vitamin C infusion increased patient performance.
2.5g Vitamin C daily for cancer patients with radiotherapy-resistant bone metastases
To reach the 2.5g levels used in this study I take half a tablespoon or 7.5ml a day of the highest strength Liposomal Vitamin C.
Published